Are Higher THC Levels In Legal Cannabis Becoming Too High
Apr 15, 2021 10:46 AM ET Legal Newswire POWERED BY LAW.COM
Most random recreational cannabis users would say, if asked, is having a higher level of THC give you a better high . The answer is Yes… and No . Different strains and different users have their own effects. Also, does a consumer really know the level of THC in the products they buy? Marijuana Business Daily addressing the recreational market said: A new study shows consumers are unable to identify cannabinoid levels in products they use. Further, 20-50 percent don t know the THC:CBD ratio of the products they normally use. This lack of consumer awareness could have implications for the safety and efficacy of therapeutic use and throws into question the reliance on self-reported cannabis potency in scientific studies. The research, carried out at the University of Waterloo in Ontario, aimed to gauge consumer understanding of THC and CBD levels of c
Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK s Cellen Therapeutics to Improve Clinician Education
USA - English
Share this article
Share this article
UK medical professionals may now earn CPD credits through Khiron s medical cannabis education program
The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training
TORONTO, April 13, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce it has received UK Continuing Professional Development ( CPD ) accredita
Khiron élargit sa gamme de produits au Royaume-Uni et améliore l accès des patients à ses produits prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Khiron Expands Product Offering in UK and Increases Patient Access
Following successful medical cannabis launch in Germany, Khiron 1/14, a high CBD flower is expected to be available in Q2/21 for UK patients
Khiron plans to introduce additional cannabis-based medical products with its registered strains, recently exported from Colombia to Europe
Supply chain improvements will increase availability of medical cannabis for patients in the United Kingdom
TORONTO, April 7, 2021 /PRNewswire/ Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to provide an operational update with regards to its supply of EU-GMP medical cannabis products to the UK. To help alleviate bottlenecks and stock outs, the Company has established an offshore inventory of dried flower, for the express purpose of serving UK patients.
Are Higher THC Levels In Legal Cannabis Becoming Too High
Financialnewsmedia.com News Commentary
Share this article
Share this article
PALM BEACH, Fla., April 7, 2021 /PRNewswire/ Most random recreational cannabis users would say, if asked, is having a higher level of THC give you a better high . The answer is Yes… and No . Different strains and different users have their own effects. Also, does a consumer really know the level of THC in the products they buy? Marijuana Business Daily addressing the recreational market said: A new study shows consumers are unable to identify cannabinoid levels in products they use. Further, 20-50 percent don t know the THC:CBD ratio of the products they normally use. This lack of consumer awareness could have implications for the safety and efficacy of therapeutic use and throws into question the reliance on self-reported cannabis potency in scientific studies. The research, carried out at the University of Waterloo in Ontario, aim